Clinical Trials Sponsored by CRO De. med Kottmann GmbH & Co

Total 46 results

Implandata Ophthalmic Products GmbH
CRO Dr. med. Kottmann GmbH & Co. KG

Active, not recruiting

Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery

Glaucoma | Open Angle Glaucoma

Germany, Switzerland
Implandata Ophthalmic Products GmbH
CRO Dr. med. Kottmann GmbH & Co. KG

Completed

Performance and Safety of the ARGOS-SC01 Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery (ARGOS-SC01)

Glaucoma | Open Angle Glaucoma

Germany, Switzerland
TransEnterix
CRO De. med Kottmann GmbH & Co; St. Marien-Krankenhays Siegen gem. GmbH Department...

Recruiting

The TransEnterix European Patient Registry (TRUST)

Surgery

Germany
AB-CT - Advanced Breast-CT GmbH
CRO Dr. med. Kottmann GmbH; RQM+ (Germany) GmbH

Recruiting

Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics

Breast Cancer Diagnosis

Netherlands, Germany
Cassella-med GmbH & Co. KG

Completed

St. John's Wort Extract LI 160 for the Treatment of Atypical Depression

Atypical Depression
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Prolytic GmbH

Completed

Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays

Allergic Rhinitis

Germany
MEDA Pharma GmbH & Co. KG

Completed

Dymista Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

Aldara for the Treatment of Large and/or Multiple sBCC

Carcinoma, Basal Cell

France
MEDA Pharma GmbH & Co. KG

Completed

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Germany
MEDA Pharma GmbH & Co. KG

Completed

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Genital Warts

Italy
MEDA Pharma GmbH & Co. KG

Completed

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Actinic Keratosis

France
IMS HEALTH GmbH & Co. OHG
EMD Serono

Completed

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif® (PROTRACT)

Relapsing-remitting Multiple Sclerosis

United States, Canada
MEDA Pharma GmbH & Co. KG

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

DYmista NAsal Spray in CHInese Patients (DYNAS-CHI)

Allergic Rhinitis

China
MEDA Pharma GmbH & Co. KG

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA)

Actinic Keratosis

Austria, Germany, France
MEDA Pharma GmbH & Co. KG

Completed

To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Atrial Fibrillation

France
MEDA Pharma GmbH & Co. KG

Recruiting

Real-world Evidence Study on Cystistat (IC/BPS)

Interstitial Cystitis and Bladder Pain Syndrome

Austria
MEDA Pharma GmbH & Co. KG

Completed

Azelastine Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

Basal Cell Carcinoma

Germany
MEDA Pharma GmbH & Co. KG

Completed

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Actinic Keratoses
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
MEDA Pharma GmbH & Co. KG

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

Diabetic Polyneuropathy

Israel, Russian Federation
Charite University, Berlin, Germany
Cassella-med GmbH & Co. KG

Completed

Efficacy of Euminz® for Tension-Type Headache (CAS/B/016611)

Episodic Tension-Type Headache

Germany
MEDA Pharma GmbH & Co. KG
Sanofi; ClinResearch, GmbH

Completed

To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol (AERIA)

Asthma, Exercise-Induced

Germany
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Prolytic GmbH; pharm-analyt GmbH

Completed

Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays

Allergic Rhinitis

Germany
Nantes University Hospital
MEDA Pharma GmbH & Co. KG

Completed

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face (ImiReduc)

Lentigo Maligna Melanoma (Head or Neck)

France
MEDA Pharma GmbH & Co. KG
3M

Terminated

Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

Atrial Fibrillation

Belgium, Bulgaria, France, Germany, Netherlands, Romania, Spain
Mylan Inc.
MEDA Pharma GmbH & Co. KG

Completed

Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients

Allergic Rhinitis

Taiwan, Thailand, Malaysia, Hong Kong
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Maastricht University Medical Center
MEDA Pharma GmbH & Co. KG

Terminated

Imiquimod Treatment of CIN Lesions (TOPIC)

Cervical Intraepithelial Neoplasia

Netherlands
MEDA Pharma GmbH & Co. KG
Accovion GmbH; Siro Clinpharm Germany GmbH (until June 2013)

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (LEIDA 2)

Actinic Keratosis

Austria, Germany
MEDA Pharma GmbH & Co. KG
ICON plc; Clinipace Worldwide; Trium Analysis Online GmbH

Terminated

Tepilta® Versus Oxetacaine, Antacids and Placebo

Radiation-induced Oesophagitis

Germany, Austria
Federal University Teaching Hospital, Feldkirch...
MEDA Pharma GmbH & Co. KG

Completed

Imiquimod and Actinic Keratoses: an Observational Study

Actinic Keratosis
University Hospital, Ghent
MEDA Pharma GmbH & Co. KG; University of Wuerzburg

Withdrawn

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

Bioavailability Study

Belgium
Groupe Hospitalier Mutualiste de Grenoble
TIMC-IMAG; Vygon GmbH & Co. KG

Completed

Prospective Analysis of Incidence and Risk Factors of Infection of Midline Catheter (TIM-GHM)

Intravascular Device

France
MEDA Pharma GmbH & Co. KG
Quintiles, Inc.; Ergomed; Clinquest, Inc.

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) (NATHAN1)

Diabetic Polyneuropathy

United States, Spain, Croatia, Denmark, France, Italy, Netherlands, Sweden, United Kingdom
University of Erlangen-Nürnberg Medical School
medi GmbH & Co. KG, Bayreuth, Germany

Completed

Effects of the "Spinomed Active" Orthosis on Chronic Back Pain in Women With Vertebral Fractures.

Osteopenia | Kyphosis

Germany
Biotronik SE & Co. KG
IHF GmbH - Institut für Herzinfarktforschung; Qmed Consulting A/S

Completed

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction (BIO-GUARD-MI)

Myocardial Infarction | Myocardial Infarction Old | Myocardial Infarction, Acute

Spain, Denmark, United States, Germany, Latvia, Australia, Czechia, Belgium, France, Austria, Hungary, Netherlands, Poland, Slovakia
Dr. August Wolff GmbH & Co. KG Arzneimittel
Dr. Dimitrios Chatsiproios; Dr. med. Klaus König; SAM®, Statistische Analysen...

Completed

Investigation on the Efficacy of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From Vulvovaginal Dryness

Vulvovaginal Atrophy

Germany
Georg Nilius, Prof DR med
Heinen und Löwenstein GmbH & Co. KG

Recruiting

Efficacy of Telemetry-assisted Care in Home Home Vented COPD (TeleInterVENT)

Chronic Obstructive Pulmonary Disease

Germany
Biocon Biologics Inc.
MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd

Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis

Bulgaria, Czechia, Estonia, Poland
ConvaTec Inc.
ClinSearch; Welsh Wound Innovation Centre; Qualizyme Diagnostics GmbH & Co KG; Perfectus... and other collaborators

Withdrawn

Analytical Performance of pH, HNE and MPO Levels in Detecting Wound Infection Proof of Concept Biomarker Study (INDICATE)

Wound Infection | Wound Heal
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Trio Clinical Research, LLC, Raleigh, USA; NuCara Pharmacy... and other collaborators

Completed

Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg

Asthma

United States
Prof. Dr. M. Dreyling (co-chairman)
ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...

Unknown

Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL ((R-HAD))

Mantle Cell Lymphoma

France, Germany
Finnish Institute for Health and Welfare
Karolinska Institutet; Medical University of Vienna; University Of Perugia; Maastricht... and other collaborators

Active, not recruiting

Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults (LETHE)

Cognitive Impairment | Dementia | Cognitive Decline

Sweden, Austria, Finland, Italy
Mats Heyman
Assistance Publique - Hôpitaux de Paris; Karolinska Institutet; Pfizer; The Swedish... and other collaborators

Recruiting

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Leukemia, Acute Lymphoblastic

Belgium, United Kingdom, Denmark, Germany, Portugal, Netherlands, Estonia, France, Finland, Iceland, Norway, Sweden, Lithuania, Ireland

Clinical Trials Sponsored by CRO De. med Kottmann GmbH & Co

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations